However, challenges persist, including its limited specificity as a standalone biomarker due to the shared increase in infections and malignancies, which necessitates combinatorial strategies with disease-specific markers like IL-17 for psoriasis (99, 100). This evidence concerns the gene IL17A and psoriasis.